Literature DB >> 11046028

NF-kappa B is required for the positive selection of CD8+ thymocytes.

T Hettmann1, J M Leiden.   

Abstract

To examine the role of NF-kappaB in T cell development, we analyzed thymocyte ontogeny in transgenic (mutant I-kappaBalpha (mI-kappaBalpha)) mice that express a superinhibitory form of the NF-kappaB inhibitory protein, I-kappaBalpha (I-kappaBalpha(A32/36)), under the control of the T cell-specific CD2 promoter and enhancer. Thymi from mI-kappaBalpha mice contained increased numbers of double-positive (DP) and decreased numbers of both CD4(+) and CD8(+) single-positive cells, consistent with a block in DP thymocyte maturation. In addition, expression of CD69, a marker of positive selection, was decreased on DP thymocytes from the mI-kappaBalpha mice. To test directly whether NF-kappaB was required for positive or negative selection, we generated mI-kappaBalpha mice expressing the H-Y or 2C alphabeta TCR transgenes. Expression of the I-kappaBalpha(A32/36) transgene caused a block in the positive selection of CD8(+) single-positive cells in both strains of TCR transgenic animals. In contrast, negative selection was unaffected by expression of the I-kappaBalpha(A32/36) transgene. Taken together, these results identified a NF-kappaB-dependent transcriptional pathway that is selectively required for the positive selection of CD8(+) thymocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11046028     DOI: 10.4049/jimmunol.165.9.5004

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.

Authors:  Lie Wang; Yumei Xiong; Rémy Bosselut
Journal:  Semin Immunol       Date:  2010-10       Impact factor: 11.130

Review 2.  Emerging and diverse roles of protein kinase C in immune cell signalling.

Authors:  Seng-Lai Tan; Peter J Parker
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

3.  CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex.

Authors:  Joel L Pomerantz; Elissa M Denny; David Baltimore
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

Review 4.  Transcriptional control of thymocyte positive selection.

Authors:  Gilbert J Kersh
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  The NF-κB1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties.

Authors:  Raffi Gugasyan; Elisha Horat; Sarah A Kinkel; Fiona Ross; George Grigoriadis; Daniel Gray; Meredith O'Keeffe; Stuart P Berzins; Gabrielle T Belz; Raelene J Grumont; Ashish Banerjee; Andreas Strasser; Dale I Godfrey; Philip N Tsichlis; Steve Gerondakis
Journal:  EMBO J       Date:  2011-11-29       Impact factor: 11.598

Review 6.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

Review 7.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

8.  Essential role of TAK1 in thymocyte development and activation.

Authors:  Hong-Hsing Liu; Min Xie; Michael D Schneider; Zhijian J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-20       Impact factor: 11.205

9.  Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development.

Authors:  Xiaoming Feng; Gregory C Ippolito; Lifeng Tian; Karla Wiehagen; Soyoung Oh; Arivazhagan Sambandam; Jessica Willen; Ralph M Bunte; Shanna D Maika; June V Harriss; Andrew J Caton; Avinash Bhandoola; Philip W Tucker; Hui Hu
Journal:  Blood       Date:  2009-11-12       Impact factor: 22.113

10.  Differential role of the transcription factor NF-kappaB in selection and survival of CD4+ and CD8+ thymocytes.

Authors:  Eijiro Jimi; Ian Strickland; Reinhard E Voll; Meixiao Long; Sankar Ghosh
Journal:  Immunity       Date:  2008-10-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.